 "Aarti Drugs falls 6% as Tarapur unit impacted by explosion")
Shares of Aarti Drugs has dipped 6% to Rs 528 on the BSE in otherwise firm market after the pharmaceuticals company said that its unit in Maharashtra Industrial Development Corporation (MIDC) Tarapur has got affected by a massive explosion at the adjoining unit of Novaphene Specialties Private limited.
The aforesaid unit has contributed 16% of total revenue from operations of the Company for the period ended 31st December, 2017.
“One of the units of Aarti Drugs has been adversely affected due to massive explosion in adjoining Unit E - 107 of Novaphene Specialties Private Limited situated at Maharashtra Industrial Development Corporation (MIDC), Tarapur,” Aarti Drugs said in a regulatory filing.
The assessment of damages is under process, it added.
The stock corrected 33% from its 52-week high of Rs 785 touched on January 9, 2018 on the BSE in intra-day trade.
At 12:09 pm; Aarti Drugs was trading 5% lower at Rs 532 as compared to 1% rise in the S&P BSE Sensex. A combined 28,943 equity shares changed hands on the counter on the BSE and NSE so far.
The aforesaid unit has contributed 16% of total revenue from operations of the Company for the period ended 31st December, 2017.
“One of the units of Aarti Drugs has been adversely affected due to massive explosion in adjoining Unit E - 107 of Novaphene Specialties Private Limited situated at Maharashtra Industrial Development Corporation (MIDC), Tarapur,” Aarti Drugs said in a regulatory filing.
The assessment of damages is under process, it added.
The stock corrected 33% from its 52-week high of Rs 785 touched on January 9, 2018 on the BSE in intra-day trade.
At 12:09 pm; Aarti Drugs was trading 5% lower at Rs 532 as compared to 1% rise in the S&P BSE Sensex. A combined 28,943 equity shares changed hands on the counter on the BSE and NSE so far.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%